GREENBRIER COMPANIES INC (GBX) Fundamental Analysis & Valuation

NYSE:GBX • US3936571013

Current stock price

49.29 USD
-0.33 (-0.67%)
At close:
49.29 USD
0 (0%)
After Hours:

This GBX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. GBX Profitability Analysis

1.1 Basic Checks

  • In the past year GBX was profitable.
  • In the past year GBX had a positive cash flow from operations.
  • GBX had positive earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: GBX reported negative operating cash flow in multiple years.
GBX Yearly Net Income VS EBIT VS OCF VS FCFGBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.42%, GBX is in line with its industry, outperforming 48.09% of the companies in the same industry.
  • GBX has a Return On Equity (9.48%) which is in line with its industry peers.
  • GBX has a Return On Invested Capital of 3.99%. This is comparable to the rest of the industry: GBX outperforms 40.46% of its industry peers.
  • GBX had an Average Return On Invested Capital over the past 3 years of 6.26%. This is below the industry average of 10.00%.
Industry RankSector Rank
ROA 3.42%
ROE 9.48%
ROIC 3.99%
ROA(3y)3.34%
ROA(5y)2.44%
ROE(3y)9.98%
ROE(5y)7.22%
ROIC(3y)6.26%
ROIC(5y)4.32%
GBX Yearly ROA, ROE, ROICGBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • GBX has a Profit Margin (5.12%) which is in line with its industry peers.
  • GBX's Profit Margin has improved in the last couple of years.
  • GBX has a Operating Margin (7.39%) which is in line with its industry peers.
  • GBX's Operating Margin has improved in the last couple of years.
  • The Gross Margin of GBX (16.16%) is worse than 80.92% of its industry peers.
  • In the last couple of years the Gross Margin of GBX has grown nicely.
Industry RankSector Rank
OM 7.39%
PM (TTM) 5.12%
GM 16.16%
OM growth 3Y57.6%
OM growth 5Y14.86%
PM growth 3Y58.73%
PM growth 5Y29.12%
GM growth 3Y22.19%
GM growth 5Y8.19%
GBX Yearly Profit, Operating, Gross MarginsGBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. GBX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBX is destroying value.
  • GBX has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GBX has been reduced compared to 5 years ago.
  • The debt/assets ratio for GBX has been reduced compared to a year ago.
GBX Yearly Shares OutstandingGBX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
GBX Yearly Total Debt VS Total AssetsGBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 1.82 indicates that GBX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • GBX has a Altman-Z score of 1.82. This is in the lower half of the industry: GBX underperforms 69.47% of its industry peers.
  • GBX has a debt to FCF ratio of 7.65. This is a slightly negative value and a sign of low solvency as GBX would need 7.65 years to pay back of all of its debts.
  • GBX has a Debt to FCF ratio of 7.65. This is comparable to the rest of the industry: GBX outperforms 45.80% of its industry peers.
  • GBX has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.13, GBX is doing worse than 80.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 7.65
Altman-Z 1.82
ROIC/WACC0.45
WACC8.92%
GBX Yearly LT Debt VS Equity VS FCFGBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 2.36 indicates that GBX has no problem at all paying its short term obligations.
  • GBX has a Current ratio of 2.36. This is comparable to the rest of the industry: GBX outperforms 59.54% of its industry peers.
  • GBX has a Quick Ratio of 1.45. This is a normal value and indicates that GBX is financially healthy and should not expect problems in meeting its short term obligations.
  • GBX's Quick ratio of 1.45 is in line compared to the rest of the industry. GBX outperforms 59.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.36
Quick Ratio 1.45
GBX Yearly Current Assets VS Current LiabilitesGBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2

3. GBX Growth Analysis

3.1 Past

  • GBX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.04%.
  • Measured over the past years, GBX shows a very strong growth in Earnings Per Share. The EPS has been growing by 26.18% on average per year.
  • GBX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.53%.
  • The Revenue has been growing slightly by 3.02% on average over the past years.
EPS 1Y (TTM)-26.04%
EPS 3Y65.49%
EPS 5Y26.18%
EPS Q2Q%-69.87%
Revenue 1Y (TTM)-17.53%
Revenue growth 3Y2.86%
Revenue growth 5Y3.02%
Sales Q2Q%-22.91%

3.2 Future

  • GBX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.96% yearly.
  • GBX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.38% yearly.
EPS Next Y-34.54%
EPS Next 2Y-15.22%
EPS Next 3Y-2.96%
EPS Next 5YN/A
Revenue Next Year-21.09%
Revenue Next 2Y-7.37%
Revenue Next 3Y-4.38%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GBX Yearly Revenue VS EstimatesGBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
GBX Yearly EPS VS EstimatesGBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

7

4. GBX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.65, which indicates a very decent valuation of GBX.
  • Compared to the rest of the industry, the Price/Earnings ratio of GBX indicates a rather cheap valuation: GBX is cheaper than 96.95% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. GBX is valued rather cheaply when compared to this.
  • GBX is valuated reasonably with a Price/Forward Earnings ratio of 10.89.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GBX indicates a rather cheap valuation: GBX is cheaper than 96.18% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of GBX to the average of the S&P500 Index (22.24), we can say GBX is valued rather cheaply.
Industry RankSector Rank
PE 10.65
Fwd PE 10.89
GBX Price Earnings VS Forward Price EarningsGBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 94.66% of the companies in the same industry are more expensive than GBX, based on the Enterprise Value to EBITDA ratio.
  • GBX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GBX is cheaper than 95.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.62
EV/EBITDA 7.85
GBX Per share dataGBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • A cheap valuation may be justified as GBX's earnings are expected to decrease with -2.96% in the coming years.
PEG (NY)N/A
PEG (5Y)0.41
EPS Next 2Y-15.22%
EPS Next 3Y-2.96%

7

5. GBX Dividend Analysis

5.1 Amount

  • GBX has a Yearly Dividend Yield of 2.74%.
  • GBX's Dividend Yield is rather good when compared to the industry average which is at 1.08. GBX pays more dividend than 93.13% of the companies in the same industry.
  • GBX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

  • The dividend of GBX has a limited annual growth rate of 3.42%.
  • GBX has paid a dividend for at least 10 years, which is a reliable track record.
  • GBX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.42%
Div Incr Years3
Div Non Decr Years11
GBX Yearly Dividends per shareGBX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • GBX pays out 27.85% of its income as dividend. This is a sustainable payout ratio.
DP27.85%
EPS Next 2Y-15.22%
EPS Next 3Y-2.96%
GBX Yearly Income VS Free CF VS DividendGBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M
GBX Dividend Payout.GBX Dividend Payout, showing the Payout Ratio.GBX Dividend Payout.PayoutRetained Earnings

GBX Fundamentals: All Metrics, Ratios and Statistics

GREENBRIER COMPANIES INC

NYSE:GBX (4/24/2026, 8:04:00 PM)

After market: 49.29 0 (0%)

49.29

-0.33 (-0.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-07
Earnings (Next)06-29
Inst Owners102.69%
Inst Owner Change0.03%
Ins Owners2.32%
Ins Owner Change15.86%
Market Cap1.53B
Revenue(TTM)2.90B
Net Income(TTM)148.30M
Analysts46
Price Target45.56 (-7.57%)
Short Float %7.82%
Short Ratio5.24
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend1.28
Dividend Growth(5Y)3.42%
DP27.85%
Div Incr Years3
Div Non Decr Years11
Ex-Date04-20
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.3%
Min EPS beat(2)-43.48%
Max EPS beat(2)42.88%
EPS beat(4)2
Avg EPS beat(4)20.92%
Min EPS beat(4)-43.48%
Max EPS beat(4)86.96%
EPS beat(8)4
Avg EPS beat(8)19.25%
EPS beat(12)7
Avg EPS beat(12)22.17%
EPS beat(16)9
Avg EPS beat(16)12%
Revenue beat(2)1
Avg Revenue beat(2)-0.36%
Min Revenue beat(2)-12.35%
Max Revenue beat(2)11.63%
Revenue beat(4)2
Avg Revenue beat(4)0.97%
Min Revenue beat(4)-12.35%
Max Revenue beat(4)11.63%
Revenue beat(8)4
Avg Revenue beat(8)-2.36%
Revenue beat(12)7
Avg Revenue beat(12)-0.61%
Revenue beat(16)11
Avg Revenue beat(16)2.83%
PT rev (1m)-10.07%
PT rev (3m)-4.96%
EPS NQ rev (1m)-34.89%
EPS NQ rev (3m)-39.26%
EPS NY rev (1m)-0.81%
EPS NY rev (3m)0.82%
Revenue NQ rev (1m)-14.41%
Revenue NQ rev (3m)-16.07%
Revenue NY rev (1m)-11.59%
Revenue NY rev (3m)-12.99%
Valuation
Industry RankSector Rank
PE 10.65
Fwd PE 10.89
P/S 0.53
P/FCF 6.62
P/OCF 3.23
P/B 0.97
P/tB 1.08
EV/EBITDA 7.85
EPS(TTM)4.63
EY9.39%
EPS(NY)4.53
Fwd EY9.19%
FCF(TTM)7.45
FCFY15.11%
OCF(TTM)15.26
OCFY30.96%
SpS93.59
BVpS50.57
TBVpS45.58
PEG (NY)N/A
PEG (5Y)0.41
Graham Number72.5811 (47.25%)
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 9.48%
ROCE 5.86%
ROIC 3.99%
ROICexc 4.63%
ROICexgc 5.21%
OM 7.39%
PM (TTM) 5.12%
GM 16.16%
FCFM 7.96%
ROA(3y)3.34%
ROA(5y)2.44%
ROE(3y)9.98%
ROE(5y)7.22%
ROIC(3y)6.26%
ROIC(5y)4.32%
ROICexc(3y)6.97%
ROICexc(5y)4.88%
ROICexgc(3y)7.92%
ROICexgc(5y)5.54%
ROCE(3y)10.03%
ROCE(5y)6.91%
ROICexgc growth 3Y47.87%
ROICexgc growth 5Y3.94%
ROICexc growth 3Y47.88%
ROICexc growth 5Y5.04%
OM growth 3Y57.6%
OM growth 5Y14.86%
PM growth 3Y58.73%
PM growth 5Y29.12%
GM growth 3Y22.19%
GM growth 5Y8.19%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 7.65
Debt/EBITDA 5.18
Cap/Depr 191.9%
Cap/Sales 8.34%
Interest Coverage 2.53
Cash Conversion 138.85%
Profit Quality 155.43%
Current Ratio 2.36
Quick Ratio 1.45
Altman-Z 1.82
F-Score5
WACC8.92%
ROIC/WACC0.45
Cap/Depr(3y)305.32%
Cap/Depr(5y)285.45%
Cap/Sales(3y)9.69%
Cap/Sales(5y)9.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.04%
EPS 3Y65.49%
EPS 5Y26.18%
EPS Q2Q%-69.87%
EPS Next Y-34.54%
EPS Next 2Y-15.22%
EPS Next 3Y-2.96%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.53%
Revenue growth 3Y2.86%
Revenue growth 5Y3.02%
Sales Q2Q%-22.91%
Revenue Next Year-21.09%
Revenue Next 2Y-7.37%
Revenue Next 3Y-4.38%
Revenue Next 5YN/A
EBIT growth 1Y-42.66%
EBIT growth 3Y62.11%
EBIT growth 5Y18.32%
EBIT Next Year2.88%
EBIT Next 3Y9.75%
EBIT Next 5YN/A
FCF growth 1Y243.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.66%
OCF growth 3YN/A
OCF growth 5Y-0.49%

GREENBRIER COMPANIES INC / GBX Fundamental Analysis FAQ

What is the fundamental rating for GBX stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBX.


What is the valuation status for GBX stock?

ChartMill assigns a valuation rating of 7 / 10 to GREENBRIER COMPANIES INC (GBX). This can be considered as Undervalued.


What is the profitability of GBX stock?

GREENBRIER COMPANIES INC (GBX) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for GBX stock?

The Price/Earnings (PE) ratio for GREENBRIER COMPANIES INC (GBX) is 10.65 and the Price/Book (PB) ratio is 0.97.


Can you provide the financial health for GBX stock?

The financial health rating of GREENBRIER COMPANIES INC (GBX) is 4 / 10.